Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sicor De México is a pharmaceutical manufacturing company based in Mexico and a subsidiary of Teva Pharmaceutical Industries. The company specializes in the production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms, particularly generic injectables and oncology medications. Operating out of a major facility in Lerma, State of Mexico, it serves as a strategic hub for Teva's operations in Latin America and global export markets. The company's portfolio includes a wide range of therapeutic solutions in areas such as central nervous system disorders, respiratory health, and pain management. Sicor De México is recognized for its high standards in chemical synthesis and compliance with international Good Manufacturing Practices (GMP).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sicor De México.